Arend Heerschap1, René D Kok, Paul P van den Berg. 1. Department of Radiology, University Medical Center St. Radboud, Geert Grooteplein Zuid 18, 6525 GA Nijmegen, The Netherlands. A.Heerschap@rad.umcn.nl
Abstract
INTRODUCTION: The assessment of metabolites in the human fetal brain in utero could have diagnostic value. We explored the feasibility and potentials of proton magnetic resonance spectroscopy ((1)H MRS) for this purpose. RESULTS: (1)H MRS was successfully performed in the third trimester of pregnancy without using sedation. Signals for inositol, choline, creatine, and N-acetylasparatate (NAA) compounds were detected in MR spectra from single voxels in the brain. Absolute tissue levels of these metabolites resemble values measured in preterm and term babies, especially of relatively more mature brain regions, from which most of the MR spectra have been obtained. Brain maturation between 30 and 41 weeks of gestation was most clearly reflected by increasing levels of the neuronal marker NAA. CONCLUSION: With proper care for the methodological aspects, antenatal (1)H MRS clearly has the potential to evolve into a clinical tool for assessing a number of key metabolites in the human fetal brain in utero.
INTRODUCTION: The assessment of metabolites in the human fetal brain in utero could have diagnostic value. We explored the feasibility and potentials of proton magnetic resonance spectroscopy ((1)H MRS) for this purpose. RESULTS: (1)H MRS was successfully performed in the third trimester of pregnancy without using sedation. Signals for inositol, choline, creatine, and N-acetylasparatate (NAA) compounds were detected in MR spectra from single voxels in the brain. Absolute tissue levels of these metabolites resemble values measured in preterm and term babies, especially of relatively more mature brain regions, from which most of the MR spectra have been obtained. Brain maturation between 30 and 41 weeks of gestation was most clearly reflected by increasing levels of the neuronal marker NAA. CONCLUSION: With proper care for the methodological aspects, antenatal (1)H MRS clearly has the potential to evolve into a clinical tool for assessing a number of key metabolites in the human fetal brain in utero.
Authors: René D Kok; Régine P M Steegers-Theunissen; Tom K A B Eskes; Arend Heerschap; Paul P van den Berg Journal: Am J Obstet Gynecol Date: 2003-04 Impact factor: 8.661
Authors: René D Kok; Paul P van den Berg; Adrianus J van den Bergh; Roel Nijland; Arend Heerschap Journal: Magn Reson Med Date: 2002-10 Impact factor: 4.668
Authors: V Berger-Kulemann; P C Brugger; D Pugash; M Krssak; M Weber; A Wielandner; D Prayer Journal: AJNR Am J Neuroradiol Date: 2012-07-19 Impact factor: 3.825
Authors: Ali Gholipour; Judith A Estroff; Carol E Barnewolt; Richard L Robertson; P Ellen Grant; Borjan Gagoski; Simon K Warfield; Onur Afacan; Susan A Connolly; Jeffrey J Neil; Adam Wolfberg; Robert V Mulkern Journal: Concepts Magn Reson Part A Bridg Educ Res Date: 2014-11 Impact factor: 0.481
Authors: E M Augustine; D M Spielman; P D Barnes; T L Sutcliffe; J D Dermon; M Mirmiran; D B Clayton; R L Ariagno Journal: J Perinatol Date: 2008-07-10 Impact factor: 2.521